News Polsky Accelerator Debuts Two Tracks — Build and Launch — and Selects 17 Teams Amid Soaring Applications for the Summer Program The Polsky Center for Entrepreneurship and Innovation is pleased to announce the 17 teams selected to participate in the 2021 Polsky Accelerator, a competitive 10-week summer program that for the...
News Meet the Teams Selected to Participate in the 2022 Edward L. Kaplan, ’71, New Venture Challenge The Polsky Center for Entrepreneurship and Innovation is pleased to announce the 30 teams selected to participate in Phase II of the 2022 Edward L. Kaplan, ’71, New Venture Challenge...
News 16 Teams Advance in the 2021 John Edwardson, ’72, Social New Venture Challenge This week, 16 teams advanced to the next round of the 2021 John Edwardson, ’72, Social New Venture Challenge (SNVC). With the announcement, teams move on to Phase II of the...
News UChicago Grants InFlectis BioScience Exclusive Rights to a Potential New Class of Therapies for Neuromuscular Diseases The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has granted InFlectis BioScience rights to use a patented family of small molecules for the treatment of neuromuscular diseases. Per the...
Technology Therapeutic Exosomes for Multiple Sclerosis and Other Demyelinating Diseases Multiple Sclerosis (MS) is caused by degradation of the protective myelin sheath that surrounds nerve fibers in the brain and spinal cord. Current MS therapies only stop the progression of…
